Our portfolio

InSteps

Providing in-silico modeling for stroke treatment, InSteps develops a platform to simulate various stroke scenarios. Their technology aids in the development of thrombectomy devices and optimizes clinical trials, giving more patients access to life-saving treatments. The company is committed to enhancing stroke care through advanced simulation technology.

Industry: Neuroscience, Simulation, Stroke

Want to get in contact about InSteps?

We’re happy to connect. Reach out to our investment manager working with the team to learn more or explore potential opportunities.

Marc Roelofs

Life Science & Health

Our portfolio

Check out similar ventures

Pioneering gene therapy, uniQure develops transformative treatments using its AAV-based technology platform.
Developing RNA-based therapies for rare genetic heart diseases.
Preventing post-surgical complications with the PURE pericardial flushing device.
Developing bispecific antibodies as enhanced cancer immunotherapy.
Pioneering gene therapy, uniQure develops transformative treatments using its AAV-based technology platform.
Developing RNA-based therapies for rare genetic heart diseases.
Preventing post-surgical complications with the PURE pericardial flushing device.
Developing bispecific antibodies as enhanced cancer immunotherapy.